Cargando…
Outcome and validation of a new clinically based staging system for predicting survival of perihilar cholangiocarcinoma patients
BACKGROUND AND AIM: Currently available staging systems for cholangiocarcinoma (CCA) are not applicable to patients with unresectable stage. A new clinical staging system for perihilar CCA (pCCA) subtype has been recently developed in a US cohort, with a good performance in predicting survival of al...
Autores principales: | Laoveeravat, Passisd, Jaruvongvanich, Veeravich, Wongjarupong, Nicha, Linlawan, Sittikorn, Tanpowpong, Natthaporn, Phathong, Chonlada, Phatharacharukul, Parkpoom, Treeprasertsuk, Sombat, Rerknimitr, Rungsun, Chaiteerakij, Roongruedee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207049/ https://www.ncbi.nlm.nih.gov/pubmed/30483535 http://dx.doi.org/10.1002/jgh3.12009 |
Ejemplares similares
-
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
por: Wongjarupong, Nicha, et al.
Publicado: (2017) -
Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis
por: Yongpisarn, Tanat, et al.
Publicado: (2021) -
Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022) -
Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography
por: Teeratorn, Nicha, et al.
Publicado: (2019) -
Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)